What are the recommended magnesium sulfate (MgSO₄) dosing regimens for adults, pregnant patients with severe pre‑eclampsia/eclampsia, torsades de pointes, and children?

Magnesium Sulfate Dosing

For severe pre-eclampsia/eclampsia, administer a 4 g IV loading dose over 5-15 minutes, followed by 1 g/hour continuous infusion for 24 hours postpartum (or 24 hours after the last seizure in eclampsia). This is the standard Zuspan regimen endorsed by international guidelines and FDA labeling 1, 2, 1, 3.

Severe Pre-eclampsia and Eclampsia (Pregnant Patients)

Loading Dose

• 4 g IV over 5-15 minutes 1, 2, 3
• Alternative (resource-limited settings): 10 g IM (5 g in each buttock) can be given simultaneously with or instead of IV loading 1, 3

Maintenance Dose

• 1 g/hour IV continuous infusion 1, 3
• Alternative: 5 g IM every 4 hours in alternating buttocks 1, 3
• Some clinicians use 1-2 g/hour, but 1 g/hour is standard 3

Duration

• 24 hours postpartum OR 24 hours after last seizure (whichever is longer) 1
• In resource-limited settings where at least 8 g was given before delivery, stopping at delivery may be acceptable, though 24-hour continuation remains preferred 1

Recurrent Seizures

• 2-4 g IV bolus over 5-15 minutes 2, 3

Critical Monitoring

Before each dose, verify:

• Patellar reflexes present (loss occurs at 3.5-5 mmol/L)
• Respiratory rate ≥12/minute (depression at 5-6.5 mmol/L)
• Urine output ≥25-30 mL/hour 1, 3

Serum magnesium monitoring is NOT routinely needed unless toxicity is suspected or renal impairment exists 2. Therapeutic range is 4.8-8.4 mg/dL (2-3.5 mmol/L) 3, 4.

Special Populations

Obese patients (BMI ≥35): Consider higher dosing—6 g IV loading dose followed by 2 g/hour maintenance—as standard dosing achieves subtherapeutic levels in 100% of obese women 5.

Renal insufficiency: Maximum 20 g/48 hours with frequent serum monitoring 3.

Important caveat: Do NOT use magnesium sulfate continuously beyond 5-7 days in pregnancy as it causes fetal abnormalities 3.

Torsades de Pointes (Adults)

1-2 g IV bolus over 5-15 minutes, repeated as needed to suppress ectopy 6, 7. Administer even if serum magnesium is normal, as it suppresses torsades without necessarily shortening QT 6. For life-threatening cases, give rapidly; otherwise infuse over 10-20 minutes 8.

Maximum single dose: 2 g 8, 7

Pediatric Dosing

25-50 mg/kg IV over 10-20 minutes (faster in torsades de pointes) 8

• Maximum dose: 2 g 8

For neonatal neuroprotection (extremely preterm delivery <32 weeks): This indication uses the maternal dosing regimen above, as the drug crosses the placenta 9.

Asthma Exacerbations

Life-threatening exacerbations only: Consider 2 g IV in adults after 1 hour of intensive conventional treatment has failed 10. This is a conditional recommendation with no apparent value in less severe exacerbations 10.

Key Clinical Pitfalls

1. Avoid sublingual/rapid IV calcium channel blockers with magnesium—combination causes myocardial depression 11

2. Toxicity progression: Loss of reflexes (3.5-5 mmol/L) → respiratory paralysis (5-6.5 mmol/L) → altered cardiac conduction (>7.5 mmol/L) → cardiac arrest (>12.5 mmol/L) 4

3. Antidote for toxicity: 10% calcium gluconate 10 mL IV over 3 minutes

4. Fluid restriction: Limit to 60-80 mL/hour in pre-eclampsia to prevent pulmonary edema 1

5. Route matters: IV provides therapeutic levels immediately; IM takes 60 minutes 3

6. Concentration for IV infusion: Must dilute to ≤20% concentration 3

The evidence strongly supports magnesium sulfate as first-line for eclampsia prevention (NNT ~100 to prevent one seizure) 1, with the MAGPIE trial establishing definitive benefit 1. In low-resource settings, ALL women with pre-eclampsia should receive magnesium sulfate 1. In high-resource settings, selective use for severe features is reasonable 1.